| calcium channel, voltage-dependent, gamma subunit 4 | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | cannabinoid receptor 1 (brain) | NIMODIPINE | Cannabinoid CB1 | 75% | 1.736uM | 1.371uM | View | 
          
            
                | mu-opioid receptor MOR | RESERPINE | Opiate mu | 75% | 4.152uM | 1.686uM | View | 
          
            
                | carbonic anhydrase VA, mitochondrial | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase IV | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase III, muscle specific | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase I | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 3 polypeptide | HEXACHLOROPHENE | ATPase, Na+/K+ | 78% | 6.1319uM | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 2 polypeptide | HEXACHLOROPHENE | ATPase, Na+/K+ | 78% | 6.1319uM | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 1 polypeptide | HEXACHLOROPHENE | ATPase, Na+/K+ | 78% | 6.1319uM | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, beta 1 polypeptide | HEXACHLOROPHENE | ATPase, Na+/K+ | 78% | 6.1319uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | PERGOLIDE | Calcium Channel Type L, Benzothiazepine | 78% | 3.301uM | 2.934uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | PERGOLIDE | Calcium Channel Type L, Benzothiazepine | 78% | 3.301uM | 2.934uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | PERGOLIDE | Calcium Channel Type L, Benzothiazepine | 78% | 3.301uM | 2.934uM | View | 
          
            
                | androgen receptor | ETHYNODIOL DIACETATE | Testosterone | 78% | 3.1uM | 2.067uM | View | 
          
            
                | adrenergic receptor, alpha 2b | GW-1929 | Adrenergic alpha2B | 78% | 19.903uM | 9.086uM | View | 
          
            
                | A3 adenosine receptor | GW-1929 | Adenosine A3 | 78% | 14.318uM | 8.093uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2A | METOCLOPRAMIDE | Serotonin 5-HT2A | 78% | 3.675uM | 1.05uM | View | 
          
            
                | matrix metallopeptidase 9 | ECONAZOLE | Protease, Matrix Metalloprotease-9 (MMP-9) | 78% | 6.997uM | NoneNone | View | 
          
            
                | matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | ECONAZOLE | Protease, Matrix Metalloprotease-9 (MMP-9) | 78% | 6.997uM | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | MICONAZOLE | CYP450-2D6 Inhibition | 78% | 1uM | NoneNone | View | 
          
            
                | Cytochrom P450-2C19 monooxygenase | (R)-BICALUTAMIDE | CYP450-2C19 Inhibition | 78% | 1uM | NoneNone | View | 
          
            
                | dopamine receptor D1A | CIGLITAZONE | Dopamine D1 | 78% | 19.785uM | 9.893uM | View | 
          
            
                | cholinergic receptor, muscarinic 2 | DEXCHLORPHENIRAMINE | Muscarinic M2 | 78% | 6.994uM | 2.487uM | View | 
          
            
                | acetylcholinesterase (YT blood group) | CIGLITAZONE | Acetylcholinesterase | 78% | 15.026uM | NoneNone | View | 
          
            
                | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | CIGLITAZONE | Acetylcholinesterase | 78% | 15.026uM | NoneNone | View | 
          
            
                | acetylcholinesterase | CIGLITAZONE | Acetylcholinesterase | 78% | 15.026uM | NoneNone | View | 
          
            
                | adenosine A2a receptor | DIETHYLSTILBESTROL | Adenosine A2A | 78% | 9.013uM | 5.06uM | View | 
          
            
                | tachykinin receptor 2 | 4-OCTYLPHENOL | Tachykinin NK2 | 78% | 17.43uM | 5.81uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2C | PHENOTHIAZINE | Serotonin 5-HT2C | 78% | 2.236uM | 1.171uM | View | 
          
            
                | dopamine receptor 2 | AMITRIPTYLINE | Dopamine D2L | 78% | 1.009uM | .336uM | View | 
          
            
                | cholinergic receptor, muscarinic 1 | AMOXAPINE | Muscarinic M1 | 78% | 1.192uM | .287uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | CHLOROXYLENOL | Serotonin 5-HT2B | 78% | 1.856uM | 1.181uM | View | 
          
            
                | dopamine receptor D4 | AMIODARONE | Dopamine D4.2 | 78% | 17.72uM | 6.213uM | View | 
          
            
                | aldo-keto reductase family 1, member B4 (aldose reductase) | ETHACRYNIC ACID | Aldose Reductase | 78% | 1.15uM | NoneNone | View | 
          
            
                | aldo-keto reductase family 1, member B1 (aldose reductase) | ETHACRYNIC ACID | Aldose Reductase | 78% | 1.15uM | NoneNone | View | 
          
            
                | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | ETHACRYNIC ACID | Aldose Reductase | 78% | 1.15uM | NoneNone | View | 
          
            
                | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | ETHACRYNIC ACID | Aldose Reductase | 78% | 1.15uM | NoneNone | View | 
          
            
                | Sigma-2 Receptor | TAMOXIFEN | Sigma2 | 78% | .619uM | .381uM | View | 
          
            
                | arachidonate 15-lipoxygenase, second type | NIFEDIPINE | Lipoxygenase 15-LO | 78% | 15.101uM | NoneNone | View | 
          
            
                | arachidonate 15-lipoxygenase | NIFEDIPINE | Lipoxygenase 15-LO | 78% | 15.101uM | NoneNone | View | 
          
            
                | arachidonate 15-lipoxygenase | NIFEDIPINE | Lipoxygenase 15-LO | 78% | 15.101uM | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | ATROPINE | Adrenergic alpha1D | 78% | 1.354uM | .666uM | View | 
          
            
                | adrenergic receptor, alpha 2b | CINNARIZINE | Adrenergic alpha2B | 78% | 2.242uM | 1.023uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | CLEMASTINE | Calcium Channel Type L, Benzothiazepine | 78% | 2.241uM | 1.992uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | phosphodiesterase 5A, cGMP-specific | TANNIC ACID | Phosphodiesterase PDE5 | 77% | 4.703uM | NoneNone | View | 
          
            
                | phosphodiesterase 5A, cGMP-specific | TANNIC ACID | Phosphodiesterase PDE5 | 77% | 4.703uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | AMOXAPINE | Calcium Channel Type L, Phenylalkylamine | 77% | 3.507uM | 3.409uM | View | 
          
            
                | nuclear receptor subfamily 3, group C, member 1 | CLOTRIMAZOLE | Glucocorticoid | 77% | 3.258uM | 1.481uM | View | 
          
            
                | cholinergic receptor, muscarinic 3 | AMIODARONE | Muscarinic M3 | 77% | 3.201uM | .679uM | View | 
          
            
                | histamine receptor H 2 | CIMETIDINE | Histamine H2 | 77% | 5.523uM | 5.431uM | View | 
          
            
                | histamine receptor H 2 | TAMOXIFEN | Histamine H2 | 77% | 9.396uM | 9.24uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | PROMAZINE | Calcium Channel Type L, Benzothiazepine | 77% | 3.217uM | 2.86uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | PROMAZINE | Calcium Channel Type L, Benzothiazepine | 77% | 3.217uM | 2.86uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | epidermal growth factor receptor | GOLD SODIUM THIOMALATE | Protein Tyrosine Kinase, EGF Receptor | 76% | 2.379uM | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1A | BRIMONIDINE | Serotonin 5-HT1A | 76% | 2.551uM | 1.458uM | View | 
          
            
                | opioid receptor, sigma 1 | CLOMIPRAMINE | Sigma1 | 76% | 1.362uM | .572uM | View | 
          
            
                | histamine receptor H 2 | CLOZAPINE | Histamine H2 | 76% | 3.61uM | 3.55uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2C | TETRACAINE | Serotonin 5-HT2C | 76% | 3.268uM | 1.712uM | View | 
          
            
                | adrenergic receptor, alpha 2a | CARVEDILOL | Imidazoline I2, Central | 76% | 1.92uM | 1.28uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | CARVEDILOL | Imidazoline I2, Central | 76% | 1.92uM | 1.28uM | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | FLUOXETINE | CYP450-2D6 Inhibition | 76% | .7uM | NoneNone | View | 
          
            
                | dopamine receptor D4 | FLUPHENAZINE | Dopamine D4.2 | 76% | 5.877uM | 2.061uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | HALOPERIDOL | Adrenergic, Norepinephrine Transporter | 76% | 1.836uM | 1.82uM | View | 
          
            
                | dopamine receptor D1A | BROMOCRIPTINE | Dopamine D1 | 76% | 2.889uM | 1.444uM | View | 
          
            
                | adrenergic receptor, alpha 1a | LYSERGOL | Adrenergic alpha1A | 76% | 3.337uM | 1.351uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | METHYSERGIDE | Calcium Channel Type L, Benzothiazepine | 76% | 3.559uM | 3.164uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | PAROXETINE | Calcium Channel Type L, Phenylalkylamine | 76% | .747uM | .726uM | View | 
          
            
                | carbonic anhydrase XIV | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase VB, mitochondrial | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase XII | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase VI | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase II | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase 5a, mitochondrial | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase 3 | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase 2 | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase 4 | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase XI | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase IX | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase VIII | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | carbonic anhydrase VII | VALDECOXIB | Carbonic Anhydrase | 75% | 4.574uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | SIBUTRAMINE | Calcium Channel Type L, Benzothiazepine | 75% | .809uM | .719uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, beta | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View | 
          
            
                | sodium channel, voltage-gated, type III, alpha | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View | 
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View | 
          
            
                | sodium channel, voltage-gated, type I, alpha | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, beta | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View | 
          
            
                | sodium channel associated protein 1 | DOXORUBICIN | Sodium Channel, Site 2 | 75% | 15.245uM | 13.668uM | View |